Informa Life Sciences is part of the Knowledge and Networking Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


21 - 23 May 2019
The Hotel Brussels,


Thank you to everyone who attended the 2018 EU Pharmaceutical Law Forum!

Stay tuned for 2019...we are working on an even more exciting agenda to ensure the latest updates from the industry's best in In-House Counsel and Private Practice


Join our webinar, sponsored by DLA Piper UK LLP, covering the trends and recent developments at EU and national competition authorities' level regarding cases of abuse of dominance which are most relevant for the Life Sciences sector, such as:

•Discounts - including in case of generic/biosimilar competition
•Marketing and promotion practices in case of generic/biosimilar competition
•Excessive pricing and definition of relevant markets
•Refusal to supply

Title: New frontiers on the abuse of dominance
Date: Monday, June 18, 2018

EU pharmaceutical law can be a real minefield - let us help you navigate..

Competition Law
  • Latest EU Commission feedback on competition law
  • Lundbeck and Servier case law: Lessons learnt on reverse payment patent settlements
  • What are the latest case law and approaches for abusive dominance through excessive pricing?
  • Explore lifecycle management with respect to competition law, patents and regulatory frameworks
NEW FOR 2018: Intellectual Property (IP)
  • Immerse yourself in second medical use patents – what lessons were learnt from the Actavis vs Eli Lilly case?
  • Latest update on the structure of the Unified Patent Court (UPC) and implications for industry
  • SPCs: Latest developments and shortcomings of the regulation
  • Compulsory licensing actions in Germany: What was learnt from the Shionogi/Merck case?
Regulatory Frameworks
  • EMA and EU Commission feedback on the regulatory landscape
  • Nature and scope of the BeNeLuxA collaboration – increasing collaboration for pricing and reimbursement
  • Pharmaceutical marketing: communication with patients and digital media – what are the legal challenges?
  • Where are we going with off-label use and drug re-purposing in the EU?
Compliance: Data Privacy & Anti-Bribery
  • Data privacy in practice: What challenges have been encountered so far with EU GDPR implementation?
  • Explore sunshine and transparency laws across the EU with regards to payments to healthcare professionals
  • Mobile apps and eHealth: Delve into data privacy
  • Anti-bribery: Conducting an effective compliance program and examining the legal challenges
Licensing & Collaboration Agreements
  • Multi-party collaborations in pharma: Understand deal structuring
  • Review commercial IP issues in collaboration and licensing agreements
  • Due diligence: Licensing options and IP considerations
  • Assess the financial aspects of collaboration and licensing agreements
Time to unwind...

After a full day of insightful debates and discussions around competition law and patent litigation, all attendees are invited to join the networking reception. 

Catch up with old and new colleagues alike from in-house counsel and private practice over drinks and canapes at this end of Day One networking session..

Push the Boundaries of your Knowledge

Our evening seminar sessions provide the opportunity to dig deeper further into these essential topics:

EVENING SEMINAR A: Brexit Implications for the Pharmaceutical Industry

The UK’s exit from the EU will have a significant impact on pharmaceutical law. Broaden your insight through our expert speakers and knowledge sharing.

EVENING SEMINAR B: Implementing the EU Medical Device Regulation

The EU MDR has now come into force and will have a significant impact on industry. Find out the latest updates including reclassification, UDI, EUDAMED and plenty more.

Who will you be rubbing shoulders with?

Partners, Lawyers, Attorneys, In-House Counsel, Compliance Officers and Licensing Counsel
Leading industry companies including Pfizer, J&J, Novartis, Novo Nordisk, Astellas and many more
Influential speakers provide critical feedback on high profile case law

What did our 2017 Attendees have to say?

"Very good opportunity to get the newest information about the regulatory environment in Europe. Very compromised information"

"Great mix of presentations and panel discussions and the fact it focused on current issues rather than top level run through of legislation we should all know anyway"

"Opportunity to meet with people and network"

"Variety of topics"

Become our event partner

2018 Promotional Participants